Chwilio Deddfwriaeth

Chwiliad Uwch

Council Regulation (EEC) No 2377/90 (repealed)Dangos y teitl llawn

Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed)

Help about what version

Pa Fersiwn

Help about advanced features

Nodweddion Uwch

Rhagor o Adnoddau

PDF o Fersiynau Diwygiedig

Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

Mae hon yn eitem o ddeddfwriaeth sy’n deillio o’r UE

Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3

Status:

Point in time view as at 22/02/2005.

Changes to legislation:

There are currently no known outstanding effects for the Council Regulation (EEC) No 2377/90 (repealed), ANNEX I . Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

[F1ANNEX I U.K. LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED

Textual Amendments

1. Anti-infectious agents U.K.

1.1. Chemotheurapeutics U.K.

1.1.1. Sulfonamides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
All substances belonging to the sulfonamide group Parent drug All food-producing species 100 μg/kg Muscle The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney
Bovine, ovine, caprine 100 μg/kg Milk
1.1.2. Diamino pyrimidine derivatives U.K.
a

[F2For porcine and poultry species this MRL relates to ‘ skin and fat in natural proportions ’ .

b

For fin fish this MRL relates to ‘ muscle and skin in natural proportions ’ .]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Baquiloprim Baquiloprim Bovine 10 μg/kg Fat
300 μg/kg Liver
150 μg/kg Kidney
30 μg/kg Milk
Porcine 40 μg/kg Skin and fat
50 μg/kg Liver
50 μg/kg Kidney
[F3Trimethoprim Trimethoprim All food producing species except equidae 50 μg/kg Fat a Not for use in animals from which eggs are produced for human consumption
50 μg/kg Muscle  b
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Milk
Equidae 100 μg/kg Muscle
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney]

Textual Amendments

1.2. Antibiotics U.K.

1.2.1. Penicillins U.K.
a

[F4For intramammary use only.]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Amoxicyllin Amoxicyllin All food-producing species 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Ampicillin Ampicillin All food-producing species 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Benzylpenicillin Benzylpenicillin All food-producing species 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Cloxacillin Cloxacillin All food-producing species 300 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk
Dicloxacillin Dicloxacillin All food-producing species 300 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk
[F5Nafcillin Nafcillin All ruminants a 300 µg/kg Muscle
300 µg/kg Fat
300 µg/kg Liver
300 µg/kg Kidney
30 µg/kg Milk]
Oxacillin Oxacillin All food-producing species 300 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk
Penethamate Benzylpenicillin Bovine 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
[F6 Porcine 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney ]
[F7Phenoxymethylpenicillin Phenoxymethylpenicillin Porcine 25 μg/kg Muscle
25 μg/kg Liver
25 μg/kg Kidney ]

Textual Amendments

1.2.2. Cephalosporins U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F8Cefacetrile Cefacetrile Bovine 125 μg/kg Milk For intramammary use only]
[F9Cefalexin Cefalexin Bovine 200 μg/kg Muscle
200 μg/kg Fat
200 μg/kg Liver
1 000  μg/kg Kidney
100 μg/kg Milk ]
[F10Cefalonium Cefalonium Bovine 20 μg/kg Milk ]
[F11Cefapirin Sum of cephapirin and desacetylcephapirin Bovine 50 μg/kg Muscle
50 μg/kg Fat
100 μg/kg Kidney
60 μg/kg Milk ]
Cefazolin Cefazolin Bovine, ovine, caprine 50 μg/kg Milk
[F12Cefoperazone Cefoperazone Bovine 50 μg/kg Milk ]
Cefquinome Cefquinome Bovine 50 μg/kg Muscle
50 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney
20 μg/kg Milk
[F13 Porcine 50 μg/kg Muscle
50 μg/kg Skin + fat
100 μg/kg Liver
200 μg/kg Kidney ]
[F14 Equidae 50 μg/kg Muscle
50 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney ]
[F15Ceftiofur Sum of all residues retaining the betalactam structure expressed as desfuroylceftiofur Bovine 1 000 μg/kg Muscle
2 000 μg/kg Fat
2 000 μg/kg Liver
6 000 μg/kg Kidney
100 μg/kg [F16Milk]
Porcine 1 000 μg/kg Muscle
2 000 μg/kg Fat
2 000 μg/kg Liver
6 000 μg/kg Kidney ]

Textual Amendments

1.2.3. Quinolones U.K.
a

[F2For fin fish this MRL relates to ‘ muscle and skin in natural proportions ’ .

b

For porcine species this MRL relates to ‘ skin and fat in natural proportions ’ .]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F3Danofloxacin Danofloxacin [X1All food producing species except bovine, ovine, caprine, porcine and poultry] 100 μg/kg Muscle b
50 μg/kg Fat a
200 μg/kg Liver
200 μg/kg Kidney
Bovine, ovine, caprine 200 μg/kg Muscle
100 μg/kg Fat
400 μg/kg Liver
400 μg/kg Kidney
30 μg/kg Milk
Poultry 200 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
100 μg/kg Skin and fat
400 μg/kg Liver
400 μg/kg Kidney
Difloxacin Difloxacin All food producing species except bovine, ovine, caprine and poultry 300 μg/kg Muscle b
100 μg/kg Fat
800 μg/kg Liver
600 μg/kg Kidney
Bovine, ovine, caprine 400 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
100 μg/kg Fat
1 400  μg/kg Liver
800 μg/kg Kidney
Porcine 400 μg/kg Muscle
100 μg/kg Skin and fat
800 μg/kg Liver
800 μg/kg Kidney
Poultry 300 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
400 μg/kg Skin and fat
1 900  μg/kg Liver
600 μg/kg Kidney
Enrofloxacin Sum of enrofloxacin and ciprofloxacin All food producing species except bovine, ovine, caprine, porcine, rabbits and poultry 100 μg/kg Muscle b
100 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
Bovine, ovine, caprine 100 μg/kg Muscle
100 μg/kg Fat
300 μg/kg Liver
200 μg/kg Kidney
100 μg/kg Milk
Porcine, rabbits 100 μg/kg Muscle
100 μg/kg Fat a
200 μg/kg Liver
300 μg/kg Kidney
Poultry 100 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
100 μg/kg Skin and fat
200 μg/kg Liver
300 μg/kg Kidney
Flumequine Flumequine All food producing species except bovine, ovine, caprine, porcine, poultry and fin fish 200 μg/kg Muscle
250 μg/kg Fat
500 μg/kg Liver
1 000  μg/kg Kidney
Bovine, porcine, ovine, caprine 200 μg/kg Muscle
300 μg/kg Fat a
500 μg/kg Liver
1 500  μg/kg Kidney
50 μg/kg Milk
Poultry 400 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
250 μg/kg Skin and fat
800 μg/kg Liver
1 000  μg/kg Kidney
Fin fish 600 μg/kg Muscle and skin in natural proportion ]
[F17Marbofloxacin Marbofloxacin Bovine 150 μg/kg Muscle
50 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
75 μg/kg Milk
Porcine 150 μg/kg Muscle
50 μg/kg Skin and fat
150 μg/kg Liver
150 μg/kg Kidney ]
[F18Oxolinic acid Oxolinic acid Porcine 100 μg/kg Muscle
50 μg/kg Skin and fat
150 μg/kg Liver
150 μg/kg Kidney
Chicken 100 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
50 μg/kg Skin and fat
150 μg/kg Liver
150 μg/kg Kidney
Fin fish 100 μg/kg Muscle and skin in natural proportions ]
Sarafloxacin Sarafloxacin Chicken 10 μg/kg Skin and fat
100 μg/kg Liver
Salmonidae 30 μg/kg Muscle and skin in natural proportions

Editorial Information

Textual Amendments

1.2.4. Macrolides U.K.
a

[F2For fin fish this MRL relates to a ‘ muscle and skin in natural proportions ’ .

b

For procine species this MRL relates to ‘ skin and fat in natural proportions ’ .

c

For porcine and poultry species this MRL relates to ‘ skin and fat in natural proportions ’ .

d

[F19 [X2Not for use in animals from which milk is produced for human consumption.] ] ]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F20Acetylisovaleryltylosin Sum of acetyl-isovaleryltylosin and 3-O-acetyltylosin Porcine 50 μg/kg Muscle
50 μg/kg Skin and fat
50 μg/kg Liver
50 μg/kg Kidney ]
[F3Erythromycin Erythromicyin A All food producing species 200 μg/kg Muscle  a
200 μg/kg Fat  b
200 μg/kg Liver
200 μg/kg Kidney
40 μg/kg Milk
150 μg/kg Eggs ]
Spiramycin Sum of spiramycin and neospiramycin Bovine 200 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
200 μg/kg Milk
Chicken 200 μg/kg Muscle
300 μg/kg Skin and fat
400 μg/kg Liver
[F21 Spiramycin 1 Porcine 250 μg/kg Muscle
2 000  μg/kg Liver
1 000  μg/kg Kidney ]
[F3Tilmicosin Tilmicosin All food producing species except poultry 50 μg/kg Muscle  a
50 μg/kg Fat  b
1 000  μg/kg Liver
1 000  μg/kg Kidney
50 μg/kg Milk
Poultry 75 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
75 μg/kg Sin and fat
1 000  μg/kg Liver
250 μg/kg Kidney
[F19 [X2Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopy-ranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Bovine d 100  μg/kg Fat
3 000  μg/kg Liver
3 000  μg/kg Kidney
Porcine 100  μg/kg Skin + fat
3 000  μg/kg Liver
3 000  μg/kg Kidney ] ]
Tylosin Tylosin A All food producing species 100 μg/kg Fat  c
100 μg/kg Muscle  a
100 μg/kg Liver
100 μg/kg Kidney
50 μg/kg Milk
200 μg/kg Eggs ]

Editorial Information

Textual Amendments

1.2.5. Florfenicol and related compounds U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F3Florfenicol Sum of florfenicol and its metabolites measured as florfenicol-amine All food producing species except bovine, ovine, caprine, porcine, poultry and fin fish 100 μg/kg Muscle
200 μg/kg Fat
2 000  μg/kg Liver
300 μg/kg Kidney
Bovine, ovine, caprine 200 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
[X33 000 μg/kg] [X3Liver]
300 μg/kg Kidney
Porcine 300 μg/kg Muscle
500 μg/kg Skin and fat
2 000  μg/kg Liver
500 μg/kg Kidney
Poultry 100 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
200 μg/kg Skin and fat
2 500  μg/kg Liver
750 μg/kg Kidney
Fin fish 1 000  μg/kg Muscle and skin in natural proportions ]
Thiamphenicol Thiamphenicol Bovine 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Milk
Chicken 50 μg/kg Muscle
Not for use in animals from which eggs are produced for human consumption 50 μg/kg Skin and fat
50 μg/kg Liver
50 μg/kg Kidney

Editorial Information

1.2.6. Tetracyclines U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Chlortetracycline Sum of parent drug and its 4- epimer All food-producing species 100 μg/kg Muscle
300 μg/kg Liver
600 μg/kg Kidney
100 μg/kg Milk
200 μg/kg Eggs
Doxycycline Doxycycline Bovine 100 μg/kg Muscle
Not for use in animals from which milk is produced for human consumption 300 μg/kg Liver
600 μg/kg Kidney
Porcine 100 μg/kg Muscle
300 μg/kg Skin and fat
300 μg/kg Liver
600 μg/kg Kidney
Poultry 100 μg/kg Muscle
Not for use in animals from which eggs are produced for human consumption 300 μg/kg Skin and fat
300 μg/kg Liver
600 μg/kg Kidney
Oxytetracycline Sum of parent drug and its 4-epimer All food-producing species 100 μg/kg Muscle
300 μg/kg Liver
600 μg/kg Kidney
100 μg/kg Milk
200 μg/kg Eggs
Tetracycline Sum of parent drug and its 4-epimer All food-producing species 100 μg/kg Muscle
300 μg/kg Liver
600 μg/kg Kidney
100 μg/kg Milk
200 μg/kg Eggs
1.2.7. Naphtalene-ringed ansamycin U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Rifaximin Rifaximin Bovine 60 μg/kg Milk
1.2.8. Pleuromutilines U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F9Tiamulin Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin Porcine 100 μg/kg Muscle
500 μg/kg Liver
Chicken 100 μg/kg Muscle
100 μg/kg Skin and fat
1 000  μg/kg Liver
[F17Rabbits 100 μg/kg Muscle
500 μg/kg Liver ]
[F12Turkey 100 μg/kg Muscle
100 μg/kg Skin and fat
300 μg/kg Liver ]
Tiamulin 1 000  μg/kg Eggs ]
Valnemulin Valnemulin Porcine 50 μg/kg Muscle
500 μg/kg Liver
100 μg/kg Kidney
[F151.2.9. Lincosamides U.K.
a

[F2For porcine and poultry species this MRL relates to ‘ skin and fat in natural proportions ’ .

b

For fin fish this MRL relates to ‘ muscle and skin in natural proportions ’ .] ]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F3Lincomycin Lincomicyn All food producing species 50 μg/kg Fat  a
100 μg/kg Muscle  b
500 μg/kg Liver
1 500  μg/kg Kidney
150 μg/kg Milk
50 μg/kg Eggs ]
[F17Pirlimycin Pirlimycin Bovine 100 μg/kg Muscle
100 μg/kg Fat
1 000  μg/kg Liver
400 μg/kg Kidney
100 μg/kg Milk
Porcine 100 μg/kg Muscle
50 μg/kg Skin and fat
500 μg/kg Liver
1 500  μg/kg Kidney
Chicken 100 μg/kg Muscle
50 μg/kg Skin and fat
500 μg/kg Liver
1 500  μg/kg Kidney
50 μg/kg Eggs ]
[F131.2.10. Aminoglycosides U.K.
a

[F2For porcine and poultry species this MRL relates to ‘ skin and fat in natural proportions ’ .

b

For fin fish this MRL relates to ‘ muscle and skin in natural proportions ’ .

c

[F22Not for use in animals from which eggs are produced for human consumption.] ] ]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Apramycin Apramycin Bovine 1 000  μg/kg Muscle Not for use in animals from which milk is produced for human consumption
1 000  μg/kg Fat
10 000  μg/kg Liver
20 000  μg/kg Kidney
[F23Dihydrostreptomycin Dihydrostreptomycin Bovine, ovine 500 μg/kg Muscle
500 μg/kg Fat
500 μg/kg Liver
1 000  μg/kg Kidney
200 μg/kg Milk
Porcine 500 μg/kg Muscle
500 μg/kg Skin and fat
500 μg/kg Liver
1 000  μg/kg Kidney ]
[F24Gentamicin Sum of gentamicin C1, gentamicin C1a, gentamicin C2 and gentamicin C2a Bovine 50 μg/kg Muscle
50 μg/kg Fat
200 μg/kg Liver
750 μg/kg Kidney
100 μg/kg Milk
Porcine 50 μg/kg Muscle
50 μg/kg Skin and fat
200 μg/kg Liver
750 μg/kg Kidney ]
[F22Kanamycin Kanamycin A All food producing species except fish c 100 μg/kg Muscle
100 μg/kg Fat a
600 μg/kg Liver
2 500  μg/kg Kidney
150 μg/kg Milk ]
[F2Neomycin (including framycetin) Neomycin B All food producing species 500 μg/kg Fat  a
500 μg/kg Muscle  b
500 μg/kg Liver
5 000  μg/kg Kidney
1 500  μg/kg Milk
500 μg/kg Eggs ]
[F3Paromomycin Paromomycin All food producing species 500 μg/kg Muscle b Not for use in animals from which milk or eggs are produced for human consumption
1 500  μg/kg Liver
1 500  μg/kg Kidney
Spectinomycin Spectinomycin All food producing species except ovine 500 μg/kg Fat a Not for use in animals from which eggs are produced for human consumption
300 μg/kg Muscle  b
1 000  μg/kg Liver
5 000  μg/kg Kidney
200 μg/kg Milk
Ovine 300 μg/kg Muscle
500 μg/kg Fat
2 000  μg/kg Liver
5 000  μg/kg Kidney
200 μg/kg Milk]
[F23Streptomycin Streptomycin Bovine, ovine 500 μg/kg Muscle
500 μg/kg Fat
500 μg/kg Liver
1 000  μg/kg Kidney
200 μg/kg Milk
Porcine 500 μg/kg Muscle
500 μg/kg Skin and fat
500 μg/kg Liver
1 000  μg/kg Kidney ]

Textual Amendments

[F211.2.11. Other antibiotics U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Novobiocin Novobiocin Bovine 50 μg/kg Milk ]
[F251.2.12. Polypeptides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Bacitracin Sum of bacitracin A, bacitracin B, and bacitracin C Bovine 100 μg/kg Milk
[F26 Rabbits 150 μg/kg Muscle
150 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney ] ]

Textual Amendments

Textual Amendments

[F111.2.13. Beta-lactamase inhibitors U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clavulanic acid Clavulanic acid Bovine 100 μg/kg Muscle
100 μg/kg Fat
200 μg/kg Liver
400 μg/kg Kidney
200 μg/kg Milk
Porcine 100 μg/kg Muscle
100 μg/kg Skin and fat
200 μg/kg Liver
400 μg/kg Kidney ]
[F21.2.14. Polymyxins U.K.
a

For porcine and poultry species this MRL relates to ‘ skin and fat in natural proportions ’ .

b

For fin fish this MRL relates to ‘ muscle and skin in natural proportions ’ .]

Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions
Colistin Colistin All food producing species 150 μg/kg Fat  a
150 μg/kg Muscle  b
150 μg/kg Liver
200 μg/kg Kidney
50 μg/kg Milk
300 μg/kg Eggs

2. Antiparasitic agents U.K.

2.1. Agents acting against endoparasites U.K.

2.1.1. Salicylanilides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Closantel Closantel Bovine 1 000  μg/kg Muscle
3 000  μg/kg Fat
1 000  μg/kg Liver
3 000  μg/kg Kidney
Ovine 1 500  μg/kg Muscle
2 000  μg/kg Fat
1 500  μg/kg Liver
5 000  μg/kg Kidney
[F25Rafoxanide Rafoxanide Bovine 30 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
30 μg/kg Fat
10 μg/kg Liver
40 μg/kg Kidney
Ovine 100 μg/kg Muscle
250 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney]
2.1.2. Tatra-hydro-imidazoles (imidazolthiazoles) U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Levamisole Levamisole Bovine, ovine, porcine, poultry 10 μg/kg Muscle
10 μg/kg Fat
100 μg/kg Liver
10 μg/kg Kidney
2.1.3. Benzimidazoles and pro-benzimidazoles U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F27Albendazole Sum of albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole All ruminants 100  μg/kg Muscle
100  μg/kg Fat
1 000  μg/kg Liver
500  μg/kg Kidney
100  μg/kg Milk]
[F28Albendazole oxide Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole Bovine, ovine 100 μg/kg Muscle
100 μg/kg Fat
1 000  μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk ]
[F27Febantel Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50  μg/kg Muscle
50  μg/kg Fat
500  μg/kg Liver
50  μg/kg Kidney
10  μg/kg Milk
Fenbendazole Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50  μg/kg Muscle
50  μg/kg Fat
500  μg/kg Liver
50  μg/kg Kidney
10  μg/kg Milk]
Flubendazole Sum of flubendazole and (2-amino 1H-benzimidazol-5-yl) (4fluorophenyl) methanone Porcine, chicken, game birds 50 μg/kg Muscle
50 μg/kg Skin and fat
400 μg/kg Liver
300 μg/kg Kidney
[F29 Turkey 50 μg/kg Muscle
50 μg/kg Skin and fat
400 μg/kg Liver
300 μg/kg Kidney ]
Flubendazole Chicken 400 μg/kg Eggs
[F30Mebendazole Sum of mebendazole methyl (5-(1-hydroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents Ovine, caprine, equidae 60 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
60 μg/kg Fat
400 μg/kg Liver
60 μg/kg Kidney]
[F12Netobimin Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole [X4Bovine, ovine] 100 μg/kg Muscle For oral use only
100 μg/kg Fat
1 000  μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk]
[F27Oxfendazole Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50  μg/kg Muscle
50  μg/kg Fat
500  μg/kg Liver
50  μg/kg Kidney
10  μg/kg Milk]
Oxibendazole Oxibendazole Porcine 100 μg/kg Muscle
500 μg/kg Skin and fat
200 μg/kg Liver
100 μg/kg Kidney
[F27Thiabendazole Sum of thiabendazole and 5-hydroxythiabendazole Caprine 100  μg/kg Muscle
100  μg/kg Fat
100  μg/kg Liver
100  μg/kg Kidney
100  μg/kg Milk]
Triclabendazole Sum of extractable residues that may be oxidised to ketotriclabendazole Bovine, ovine 100 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
100 μg/kg Liver
100 μg/kg Kidney

Editorial Information

Textual Amendments

[F312.1.4. Phenol derivatives including salicylanides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Nitroxinil Nitroxinil Bovine, ovine 400 μg/kg Muscle
200 μg/kg Fat
20 μg/kg Liver
400 μg/kg Kidney
[F27Oxyclozanide Oxyclozanide All ruminants 20  μg/kg Muscle
20  μg/kg Fat
500  μg/kg Liver
100  μg/kg Kidney
10  μg/kg Milk] ]

Textual Amendments

[F322.1.5. Benzenesulphonamides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clorsulon Clorsulon Bovine 35 μg/kg Muscle
100 μg/kg Liver
200 μg/kg Kidney ]

Textual Amendments

[F242.1.6. Piperazine derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Piperazine Piperazine Porcine 400 μg/kg Muscle
800 μg/kg Skind and fat
2 000  μg/kg Liver
1 000  μg/kg Kidney
Chicken 2 000  μg/kg Eggs ]
[F332.1.7. Tetrahydropyrimides U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Morantel Sum of residues which may be hydrolysed to N-methyl-1,3- propanediamine and expressed as morantel equivalents Bovine, ovine 100 μg/kg Muscle
100 μg/kg Fat
800 μg/kg Liver
200 μg/kg Kidney
50 μg/kg Milk ]

Textual Amendments

2.2. Agents acting against ectoparasites U.K.

2.2.1. Organophosphates U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F25Coumafos Coumafos Bees 100 μg/kg Honey ]
Diazinon Diazinon Bovine, ovine, caprine 20 μg/kg Milk
Bovine, porcine, ovine, caprine 20 μg/kg Muscle
700 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
[F12Phoxim Phoxim Ovine 50 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
400 μg/kg Fat
50 μg/kg Kidney
Porcine 20 μg/kg Muscle
700 μg/kg Skin and fat
20 μg/kg Liver
20 μg/kg Kidney]
2.2.2. Formamidines U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Amitraz Sum of amitraz and all metabolites containing the 2,4-DMA moiety, expressed as amitraz Bovine 200 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
10 μg/kg Milk
Ovine 400 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney
10 μg/kg Milk
Porcine 400 μg/kg Skin and fat
200 μg/kg Liver
200 μg/kg Kidney
[F28 Bees (honey) 200 μg/kg Honey ]
[F34 Caprine 200  μg/kg Fat
100  μg/kg Liver
200  μg/kg Kidney
10  μg/kg Milk ]

Textual Amendments

2.2.3. Pyrethroids U.K.
a

[F10Further provisions in Commission Directive 98/82/EC are to be observed ( OJ L 290, 29.10.1998, p. 25 ).]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F12 [X4Cyhalothrin Cyhalothrin (sum of isomers) Bovine 500 μg/kg Fat Further provisions in Council Directive 94/29/EC are to be observed
50 μg/kg Kidney
50 μg/kg Milk
Cyfluthrin Cyfluthrin (sum of isomers) Bovine 10 μg/kg Muscle
50 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
20 μg/kg Milk] ]
[F35 [F27Deltamethrin Deltamethrin All ruminants 10  μg/kg Muscle
50  μg/kg Fat
10  μg/kg Liver
10  μg/kg Kidney
20  μg/kg Milk]
[F8Fin fish 10 μg/kg Muscle and skin in natural proportions] ]
Flumethrin Flumethrin (sum of trans-Z isomers) Bovine 10 μg/kg Muscle
150 μg/kg Fat
20 μg/kg Liver
10 μg/kg Kidney
30 μg/kg Milk
[F36 Ovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
150 μg/kg Fat
20 μg/kg Liver
10 μg/kg Kidney ]
[F10Permethrin Permethrin (sum of isomers) Bovine 50 μg/kg Muscle
500 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Milk a ]
[F37Cypermethrin Cypermethrin (sum of isomers) Salmonidae 50 μg/kg Muscle and skin in natural proportions ]
[F27All ruminants 20  μg/kg Muscle
200  μg/kg Fat
20  μg/kg Liver
20  μg/kg Kidney
20  μg/kg Milk a ]
[F38Alphacypermethrin Cypermethrin (sum of isomers) Bovine, ovine 20 μg/kg Muscle
200 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
20 μg/kg Milk] a

Textual Amendments

[F132.2.4. Acyl urea derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F21Diflubenzuron Diflubenzuron Salmonidae 1 000  μg/kg Muscle and skin in natural proportions ]
Teflubenzuron Teflubenzuron Salmonidae 500 μg/kg Muscle and skin in natural proportions ]
[F392.2.5. Pyrimidines derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Dicyclanil Sum of dicyclanil and 2, 4, 6-triamino-pyrimidine-5-carbonitrile Ovine 200 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
[F40150 μg/kg] Fat
400 μg/kg Liver
400 μg/kg Kidney]

Textual Amendments

Textual Amendments

[F252.2.6. Triazine derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cyromazine Cyromazine Ovine 300 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney]

2.3. Agents acting against endo- and ectoparasites U.K.

2.3.1. Avermectins U.K.
Phramacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Abamectin Avermectin B1a Bovine 10 μg/kg Fat
20 μg/kg Liver
[F24 Ovine 20 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
50 μg/kg Fat
25 μg/kg Liver
20 μg/kg Kidney ]
Doramectin Doramectin Bovine 10 μg/kg Muscle Not for use in bovine from which milk is produced for human consumption
150 μg/kg Fat
100 μg/kg Liver
30 μg/kg Kidney
Porcine, ovine 20 μg/kg Muscle Not for use in ovine from which milk is produced for human consumption
100 μg/kg Fat
50 μg/kg Liver
30 μg/kg Kidney
[F25 Deer, including reindeer 20 μg/kg Muscle
100 μg/kg Fat
50 μg/kg Liver
30 μg/kg Kidney ]
[F41Emamectin Emamectin B1a Fin fish 100 μg/kg Muscle and skin in natural proportions ]
Eprinomectin Eprinomectin B1a Bovine [F4250 μg/kg] Muscle
[F42250 μg/kg] Fat
[F421 500  μg/kg] Liver
[F42300 μg/kg] Kidney
[F4220 μg/kg] Milk
Ivermectin 22, 23-Dihydro-avermectin B1a Bovine 40 μg/kg Fat
100 μg/kg Liver
Porcine, ovine, equidae 20 μg/kg Fat
15 μg/kg Liver
Deer, including reindeer 20 μg/kg Muscle
100 μg/kg Fat
50 μg/kg Liver
20 μg/kg Kidney
Moxidectin Moxidectin Bovine, ovine 50 μg/kg Muscle
500 μg/kg Fat
100 μg/kg Liver
50 μg/kg Kidney
[F11 Bovine 40 μg/kg Milk ]
[F32 Equidae 50 μg/kg Muscle
500 μg/kg Fat
100 μg/kg Liver
50 μg/kg Kidney ]

Textual Amendments

2.4. Agents acting against protozoa U.K.

2.4.1. Triazinetrione derivative U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Toltrazuril Toltrazuril sulfone Chicken 100 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
200 μg/kg Skin and fat
600 μg/kg Liver
400 μg/kg Kidney
Turkey 100 μg/kg Muscle
200 μg/kg Skin and fat
600 μg/kg Liver
400 μg/kg Kidney
[F43 Porcine 100 μg/kg Muscle
150 μg/kg Skin and fat
500 μg/kg Liver
250 μg/kg Kidney ]

Textual Amendments

[F432.4.2. Quinazolone derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Halofuginone Halofuginone Bovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
25 μg/kg Fat
30 μg/kg Liver
30 μg/kg Kidney]
[F82.4.3. Carbanilides U.K.
a

[F14Not for use in ovine from which milk is produced for human consumption.] ]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Imidocarb Imidocarb Bovine 300 μg/kg Muscle
50 μg/kg Fat
2 000  μg/kg Liver
1 500  μg/kg Kidney
50 μg/kg Milk
[F14Ovine a 300 μg/kg Muscle
50 μg/kg Fat
2 000  μg/kg Liver
1 500  μg/kg Kidney ]

3. Agents acting on the nervous system U.K.

3.1. Agents acting on the central nervous system U.K.

3.1.1. Butyrophenone tranquillisers U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Azaperone Sum of azaperone and azaperol Porcine 100 μg/kg Muscle
100 μg/kg Skin and fat
100 μg/kg Liver
100 μg/kg Kidney

3.2. Agents acting on the autonomic nervous system U.K.

3.2.1. Anti-adrenergics U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Carazolol Carazolol Porcine 5 μg/kg Muscle
5 μg/kg Skin and fat
25 μg/kg Liver
25 μg/kg Kidney
[F6 Bovine 5 μg/kg Muscle
5 μg/kg Fat
15 μg/kg Liver
15 μg/kg Kidney
1 μg/kg Milk ]
[F363.2.2. β2 sympathomimetic agents U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clenbuterol hydrochloride Clenbuterol Bovine 0,1 μg/kg Muscle
0,5 μg/kg Liver
0,5 μg/kg Kidney
0,05 μg/kg Milk
Equidae 0,1 μg/kg Muscle
0,5 μg/kg Liver
0,5 μg/kg Kidney ]

4. Anti-inflammatory agents U.K.

4.1. Nonsteroidal anti-inflammatory agents U.K.

4.1.1. Arylpropionic acid derivative U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F13Carprofen Carprofen

Bovine

Not for use in animals from which milk is produced for human consumption

500 μg/kg Muscle
1 000  μg/kg Fat
1 000  μg/kg Liver
1 000  μg/kg Kidney
Equidae 500 μg/kg Muscle
1 000  μg/kg Fat
1 000  μg/kg Liver
1 000  μg/kg Kidney ]
Vedaprofen Vedaprofen Equidae 50 μg/kg Muscle
20 μg/kg Fat
100 μg/kg Liver
1 000  μg/kg Kidney
4.1.2. Fenamate group derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F9Flunixin Flunixin Bovine 20 μg/kg Muscle
30 μg/kg Fat
300 μg/kg Liver
100 μg/kg Kidney
5-Hydroxyflunixin 40 μg/kg Milk
Flunixin Porcine 50 μg/kg Muscle
10 μg/kg Skin and fat
200 μg/kg Liver
30 μg/kg Kidney
[F43Equidae 10 μg/kg Muscle
20 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney ] ]
Tolfenamic acid Tolfenamic acid Bovine 50 μg/kg Muscle
400 μg/kg Liver
100 μg/kg Kidney
50 μg/kg Milk
Porcine 50 μg/kg Muscle
400 μg/kg Liver
100 μg/kg Kidney
[F234.1.3. Enolic acid derivates U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Meloxicam Meloxicam Equidae 20 μg/kg Muscle
65 μg/kg Liver
65 μg/kg Kidney ]
[F284.1.4. Oxican derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Meloxicam Meloxicam Bovine [F4420 μg/kg] Muscle
[F4465 μg/kg] Liver
[F4465 μg/kg] Kidney
[F915 μg/kg] [F9Milk]
[F45Porcine 20 μg/kg Muscle
65 μg/kg Liver
65 μg/kg Kidney ] ]

Textual Amendments

[F384.1.5. Pyrazolone derivatives U.K.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Metamizole 4-Methylaminoantipyrin Bovine 100 μg/kg Muscle
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney
50 μg/kg Milk
Porcine 100 μg/kg Muscle
100 μg/kg Skin and fat
100 μg/kg Liver
100 μg/kg Kidney
Equidae 100 μg/kg Muscle
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney ]
[F224.1.6. Phenyl acetic acid derivatives U.K.
a

Not for use in animals from which milk is produced for human consumption.]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Diclofenac Diclofenac Bovine a 5 μg/kg Muscle
1 μg/kg Fat
5 μg/kg Liver
10 μg/kg Kidney
Porcine 5 μg/kg Muscle
1 μg/kg Skin + fat
5 μg/kg Liver
10 μg/kg Kidney

5. Corticoides U.K.

5.1. Glucocorticoides U.K.

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
[F21Betamethasone Betamethasone Bovine 0,75 μg/kg Muscle
2,0 μg/kg Liver
0,75 μg/kg Kidney
0,3 μg/kg Milk
Porcine 0,75 μg/kg Muscle
2,0 μg/kg Liver
0,75 μg/kg Kidney ]
Dexamethasone Dexamethasone Bovine 0,3 μg/kg Milk
Bovine, porcine, equidae 0,75 μg/kg Muscle
2 μg/kg Liver
0,75 μg/kg Kidney
[F34 Caprine 0,75  μg/kg Muscle
2  μg/kg Liver
0,75  μg/kg Kidney
0,3  μg/kg Milk]
[F20Methylprednisolone Methylprednisolone Bovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
10 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney]
[F46Prednisolone Prednisolone Bovine 4 μg/kg Muscle
4 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
6 μg/kg Milk ]

Textual Amendments

[F476. Agents acting on the reproductive system U.K.

6.1. Progestogens U.K.

a

[F48Only for zootechnical use and in accordance with the provisions of Directive 96/22/EC.] ] ]

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Chlormadinone Chlormadinone Bovine 4 μg/kg Fat For zootechnical use only
2 μg/kg Liver
2,5 μg/kg Milk
Flugestone acetate Flugetone acetate Ovine 1 μg/kg Milk For intravaginal use for zootechnical purposes only
[F18Caprine 1 μg/kg Milk For intra-vaginal use for zootechnical purposes only]
[F48Altrenogest a Altrenogest Porcine 1 μg/kg Skin and fat
0,4  μg/kg Liver
Equidae 1 μg/kg Fat
0,9  μg/kg Liver]

Textual Amendments

Textual Amendments

Yn ôl i’r brig

Options/Help

Print Options

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

Gweler y wybodaeth ychwanegol ochr yn ochr â’r cynnwys

Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted version that was used for the EU Official Journal
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Llinell Amser Newidiadau

Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.

Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.

Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.

Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill